SEC Form 4 · accession 0001777631-26-000007
Serina Therapeutics, Inc. · SER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen K. Brannan
Director
Period of report
Jul 7, 2026
Accepted (ET)
Jul 9, 2026 · 12:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001708599
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 7, 2026 | P | 1,000 | $2.03 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.